530 related articles for article (PubMed ID: 20459856)
1. A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.
Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB;
Trials; 2010 May; 11():51. PubMed ID: 20459856
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
[TBL] [Abstract][Full Text] [Related]
3. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
Pancioli AM; Broderick J; Brott T; Tomsick T; Khoury J; Bean J; del Zoppo G; Kleindorfer D; Woo D; Khatri P; Castaldo J; Frey J; Gebel J; Kasner S; Kidwell C; Kwiatkowski T; Libman R; Mackenzie R; Scott P; Starkman S; Thurman RJ;
Stroke; 2008 Dec; 39(12):3268-76. PubMed ID: 18772447
[TBL] [Abstract][Full Text] [Related]
4. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.
Zinkstok SM; Roos YB;
Lancet; 2012 Aug; 380(9843):731-7. PubMed ID: 22748820
[TBL] [Abstract][Full Text] [Related]
5. Early deterioration after thrombolysis plus aspirin in acute stroke: a post hoc analysis of the Antiplatelet Therapy in Combination with Recombinant t-PA Thrombolysis in Ischemic Stroke trial.
Zinkstok SM; Beenen LF; Majoie CB; Marquering HA; de Haan RJ; Roos YB
Stroke; 2014 Oct; 45(10):3080-2. PubMed ID: 25139873
[TBL] [Abstract][Full Text] [Related]
6. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
[TBL] [Abstract][Full Text] [Related]
7. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
9. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
[TBL] [Abstract][Full Text] [Related]
11. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
[TBL] [Abstract][Full Text] [Related]
12. Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke.
Schmülling S; Rudolf J; Strotmann-Tack T; Grond M; Schneweis S; Sobesky J; Thiel A; Heiss WD
Cerebrovasc Dis; 2003; 16(3):183-90. PubMed ID: 12865603
[TBL] [Abstract][Full Text] [Related]
13. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis for acute ischaemic stroke.
Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis for acute ischaemic stroke.
Wardlaw JM; Murray V; Berge E; del Zoppo GJ
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD000213. PubMed ID: 25072528
[TBL] [Abstract][Full Text] [Related]
16. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
17. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
[TBL] [Abstract][Full Text] [Related]
19. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
Adeoye O; Knight WA; Khoury J; Schmit PA; Sucharew H; Broderick JP; Pancioli AM;
J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
[TBL] [Abstract][Full Text] [Related]
20. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]